Concepts (257)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nursing Assessment | 21 | 2012 | 27 | 2.780 |
Why?
|
| Emergency Nursing | 13 | 2010 | 13 | 2.390 |
Why?
|
| Pneumothorax | 4 | 2011 | 15 | 1.310 |
Why?
|
| Critical Care | 5 | 2011 | 48 | 1.210 |
Why?
|
| Infusions, Intraosseous | 4 | 2011 | 4 | 0.940 |
Why?
|
| Emergency Treatment | 5 | 2008 | 26 | 0.880 |
Why?
|
| Emergency Medical Services | 4 | 2011 | 78 | 0.860 |
Why?
|
| Emergencies | 7 | 2011 | 28 | 0.670 |
Why?
|
| Heat Exhaustion | 2 | 2010 | 2 | 0.650 |
Why?
|
| First Aid | 3 | 2006 | 6 | 0.590 |
Why?
|
| Humans | 40 | 2016 | 26827 | 0.570 |
Why?
|
| Sternum | 2 | 2011 | 7 | 0.550 |
Why?
|
| Extremities | 1 | 2016 | 22 | 0.520 |
Why?
|
| Transportation of Patients | 2 | 2005 | 28 | 0.490 |
Why?
|
| Heat Stroke | 2 | 2010 | 2 | 0.490 |
Why?
|
| Ruthenium | 7 | 2012 | 10 | 0.490 |
Why?
|
| Frostbite | 2 | 2008 | 2 | 0.450 |
Why?
|
| Hemorrhage | 1 | 2016 | 259 | 0.450 |
Why?
|
| Organometallic Compounds | 6 | 2013 | 40 | 0.430 |
Why?
|
| Wounds and Injuries | 2 | 2008 | 166 | 0.430 |
Why?
|
| Brain Diseases, Metabolic | 1 | 2012 | 1 | 0.400 |
Why?
|
| Diabetes Insipidus, Neurogenic | 1 | 2012 | 1 | 0.400 |
Why?
|
| Inappropriate ADH Syndrome | 1 | 2012 | 2 | 0.400 |
Why?
|
| Hyponatremia | 1 | 2012 | 16 | 0.400 |
Why?
|
| Phosphines | 6 | 2013 | 7 | 0.390 |
Why?
|
| Brain Injuries | 1 | 2012 | 49 | 0.380 |
Why?
|
| Nickel | 4 | 2012 | 15 | 0.380 |
Why?
|
| Iatrogenic Disease | 1 | 2011 | 13 | 0.380 |
Why?
|
| Wounds, Penetrating | 1 | 2011 | 23 | 0.380 |
Why?
|
| Thigh | 1 | 2011 | 39 | 0.370 |
Why?
|
| Humerus | 1 | 2011 | 10 | 0.370 |
Why?
|
| Coordination Complexes | 4 | 2012 | 26 | 0.370 |
Why?
|
| Multiple Trauma | 1 | 2011 | 23 | 0.370 |
Why?
|
| Bicycling | 1 | 2011 | 36 | 0.370 |
Why?
|
| Tibia | 1 | 2011 | 38 | 0.370 |
Why?
|
| Alkenes | 5 | 2012 | 15 | 0.360 |
Why?
|
| Hypothermia, Induced | 1 | 2010 | 6 | 0.340 |
Why?
|
| Male | 16 | 2011 | 12870 | 0.340 |
Why?
|
| Neisseria gonorrhoeae | 3 | 2017 | 6 | 0.340 |
Why?
|
| Iron | 4 | 2017 | 103 | 0.320 |
Why?
|
| Crohn Disease | 1 | 2008 | 25 | 0.310 |
Why?
|
| Accidental Falls | 1 | 2008 | 31 | 0.310 |
Why?
|
| Colitis, Ulcerative | 1 | 2008 | 28 | 0.310 |
Why?
|
| Hypertension | 1 | 2011 | 304 | 0.310 |
Why?
|
| Resuscitation | 2 | 2011 | 59 | 0.310 |
Why?
|
| Fever | 1 | 2008 | 30 | 0.310 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2010 | 279 | 0.280 |
Why?
|
| Foot Injuries | 1 | 2006 | 5 | 0.280 |
Why?
|
| Amputation, Traumatic | 1 | 2006 | 5 | 0.270 |
Why?
|
| Catheterization, Central Venous | 1 | 2006 | 36 | 0.270 |
Why?
|
| Adult | 11 | 2011 | 7383 | 0.260 |
Why?
|
| Facial Bones | 1 | 2006 | 7 | 0.260 |
Why?
|
| Skull Fractures | 1 | 2006 | 18 | 0.260 |
Why?
|
| Perioperative Nursing | 1 | 2005 | 2 | 0.260 |
Why?
|
| Conscious Sedation | 1 | 2005 | 10 | 0.250 |
Why?
|
| RNA, Bacterial | 2 | 2017 | 65 | 0.250 |
Why?
|
| Leg | 2 | 2004 | 131 | 0.250 |
Why?
|
| Knowledge | 1 | 2005 | 14 | 0.250 |
Why?
|
| Air Ambulances | 1 | 2005 | 19 | 0.250 |
Why?
|
| Health Surveys | 1 | 2005 | 77 | 0.240 |
Why?
|
| Hypertension, Malignant | 1 | 2004 | 3 | 0.240 |
Why?
|
| Rural Population | 1 | 2005 | 89 | 0.230 |
Why?
|
| Pulmonary Embolism | 1 | 2005 | 126 | 0.230 |
Why?
|
| Physical Examination | 3 | 2011 | 47 | 0.230 |
Why?
|
| Hematoma, Epidural, Cranial | 1 | 2003 | 1 | 0.220 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2004 | 44 | 0.220 |
Why?
|
| Lightning Injuries | 1 | 2003 | 1 | 0.220 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2004 | 64 | 0.220 |
Why?
|
| Terphenyl Compounds | 2 | 2013 | 2 | 0.200 |
Why?
|
| Venous Thrombosis | 1 | 2003 | 98 | 0.200 |
Why?
|
| Stroke | 1 | 2005 | 233 | 0.200 |
Why?
|
| Electric Countershock | 1 | 2001 | 29 | 0.190 |
Why?
|
| Intubation, Intratracheal | 1 | 2001 | 26 | 0.190 |
Why?
|
| Hydrogen | 2 | 2012 | 56 | 0.190 |
Why?
|
| Benzene Derivatives | 2 | 2011 | 7 | 0.190 |
Why?
|
| Amines | 2 | 2012 | 13 | 0.180 |
Why?
|
| Equipment Design | 3 | 2011 | 211 | 0.170 |
Why?
|
| Attitude to Death | 1 | 2000 | 13 | 0.170 |
Why?
|
| Acute Disease | 3 | 2005 | 153 | 0.170 |
Why?
|
| Pyridines | 2 | 2011 | 99 | 0.170 |
Why?
|
| Nursing Staff, Hospital | 1 | 2000 | 19 | 0.170 |
Why?
|
| Catheters, Indwelling | 1 | 1999 | 19 | 0.170 |
Why?
|
| Crystallography, X-Ray | 9 | 2013 | 214 | 0.170 |
Why?
|
| Risk Factors | 4 | 2008 | 2011 | 0.170 |
Why?
|
| Drug Eruptions | 1 | 1999 | 7 | 0.170 |
Why?
|
| Catheterization, Peripheral | 1 | 2000 | 24 | 0.170 |
Why?
|
| Scyphozoa | 1 | 1999 | 1 | 0.170 |
Why?
|
| Bites and Stings | 1 | 1999 | 6 | 0.170 |
Why?
|
| Compartment Syndromes | 1 | 1999 | 7 | 0.160 |
Why?
|
| Terminal Care | 1 | 2000 | 43 | 0.160 |
Why?
|
| Vancomycin | 1 | 1999 | 56 | 0.160 |
Why?
|
| Body Temperature | 2 | 2010 | 30 | 0.160 |
Why?
|
| Diaphragm | 1 | 1999 | 14 | 0.160 |
Why?
|
| Diagnosis, Differential | 2 | 2012 | 367 | 0.160 |
Why?
|
| Accidents, Traffic | 1 | 1999 | 27 | 0.160 |
Why?
|
| Attitude of Health Personnel | 1 | 2000 | 139 | 0.160 |
Why?
|
| Models, Molecular | 8 | 2013 | 441 | 0.160 |
Why?
|
| Pleural Effusion | 1 | 1998 | 14 | 0.160 |
Why?
|
| Heparin | 2 | 2003 | 110 | 0.150 |
Why?
|
| Nursing Staff | 1 | 1997 | 7 | 0.140 |
Why?
|
| Masks | 1 | 1997 | 9 | 0.140 |
Why?
|
| Infection Control | 1 | 1997 | 31 | 0.140 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 1997 | 27 | 0.140 |
Why?
|
| Heterocyclic Compounds | 2 | 2009 | 15 | 0.130 |
Why?
|
| Rubredoxins | 2 | 1992 | 2 | 0.130 |
Why?
|
| Bandages | 1 | 2016 | 9 | 0.130 |
Why?
|
| Tourniquets | 1 | 2016 | 15 | 0.130 |
Why?
|
| Archaea | 2 | 1992 | 50 | 0.120 |
Why?
|
| Gene Expression Regulation, Bacterial | 2 | 2013 | 152 | 0.120 |
Why?
|
| Anti-Bacterial Agents | 1 | 1999 | 496 | 0.120 |
Why?
|
| Ethylenes | 2 | 2012 | 5 | 0.120 |
Why?
|
| Child | 4 | 2005 | 2147 | 0.120 |
Why?
|
| Time Factors | 2 | 2011 | 1562 | 0.120 |
Why?
|
| Magnetics | 2 | 2011 | 14 | 0.110 |
Why?
|
| RNA, Small Untranslated | 1 | 2013 | 2 | 0.110 |
Why?
|
| Palladium | 1 | 2013 | 9 | 0.110 |
Why?
|
| RNA Stability | 1 | 2013 | 26 | 0.110 |
Why?
|
| Oxygen | 2 | 2012 | 218 | 0.110 |
Why?
|
| Protein Conformation | 2 | 1999 | 250 | 0.110 |
Why?
|
| Aged | 3 | 2011 | 5167 | 0.110 |
Why?
|
| Neuromuscular Blocking Agents | 1 | 1993 | 6 | 0.110 |
Why?
|
| Carbon | 2 | 2012 | 93 | 0.110 |
Why?
|
| Nitroglycerin | 1 | 1992 | 27 | 0.100 |
Why?
|
| Catalysis | 5 | 2012 | 133 | 0.100 |
Why?
|
| Molecular Structure | 6 | 2013 | 239 | 0.100 |
Why?
|
| Lewis Bases | 1 | 2012 | 1 | 0.100 |
Why?
|
| Syndrome | 1 | 2012 | 78 | 0.100 |
Why?
|
| Ligands | 5 | 2011 | 168 | 0.100 |
Why?
|
| Hospital Rapid Response Team | 1 | 2011 | 1 | 0.100 |
Why?
|
| Photosystem II Protein Complex | 1 | 2011 | 3 | 0.100 |
Why?
|
| Manganese | 1 | 2011 | 22 | 0.100 |
Why?
|
| Bridged-Ring Compounds | 1 | 2011 | 18 | 0.100 |
Why?
|
| Drug Administration Routes | 1 | 2011 | 8 | 0.090 |
Why?
|
| Transition Elements | 1 | 2011 | 2 | 0.090 |
Why?
|
| Trees | 1 | 2011 | 45 | 0.090 |
Why?
|
| Oxidation-Reduction | 5 | 2011 | 354 | 0.090 |
Why?
|
| Bacterial Proteins | 2 | 2017 | 474 | 0.090 |
Why?
|
| Copper | 1 | 2011 | 44 | 0.090 |
Why?
|
| Calcium | 1 | 2011 | 231 | 0.090 |
Why?
|
| Trauma Centers | 1 | 2011 | 114 | 0.090 |
Why?
|
| Molecular Conformation | 4 | 2011 | 66 | 0.090 |
Why?
|
| Regulon | 1 | 2010 | 18 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2010 | 114 | 0.080 |
Why?
|
| Benzylidene Compounds | 1 | 2009 | 29 | 0.080 |
Why?
|
| Cryotherapy | 1 | 2008 | 10 | 0.080 |
Why?
|
| Polymers | 1 | 2009 | 114 | 0.080 |
Why?
|
| Hypothalamus | 1 | 2008 | 29 | 0.080 |
Why?
|
| Medical History Taking | 1 | 2008 | 18 | 0.080 |
Why?
|
| Body Temperature Regulation | 1 | 2008 | 12 | 0.080 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2008 | 8 | 0.080 |
Why?
|
| Immobilization | 1 | 2008 | 15 | 0.080 |
Why?
|
| Swimming | 1 | 2008 | 31 | 0.080 |
Why?
|
| Quantum Theory | 3 | 2013 | 19 | 0.070 |
Why?
|
| X-Ray Diffraction | 4 | 2009 | 41 | 0.070 |
Why?
|
| Patient Education as Topic | 1 | 2008 | 87 | 0.070 |
Why?
|
| Methane | 2 | 2009 | 48 | 0.070 |
Why?
|
| Female | 4 | 2008 | 14463 | 0.070 |
Why?
|
| Thoracostomy | 1 | 2006 | 4 | 0.070 |
Why?
|
| Replantation | 1 | 2006 | 7 | 0.070 |
Why?
|
| Chest Tubes | 1 | 2006 | 9 | 0.070 |
Why?
|
| Respiration, Artificial | 1 | 2006 | 39 | 0.070 |
Why?
|
| Imidazoles | 2 | 2003 | 60 | 0.070 |
Why?
|
| Carbon Dioxide | 1 | 2007 | 85 | 0.070 |
Why?
|
| Maxillary Fractures | 1 | 2006 | 1 | 0.070 |
Why?
|
| Zygomatic Fractures | 1 | 2006 | 2 | 0.070 |
Why?
|
| Nasal Bone | 1 | 2006 | 5 | 0.070 |
Why?
|
| Causality | 1 | 2006 | 13 | 0.070 |
Why?
|
| Tooth Fractures | 1 | 2006 | 3 | 0.070 |
Why?
|
| Orbital Fractures | 1 | 2006 | 6 | 0.070 |
Why?
|
| Baseball | 1 | 2006 | 10 | 0.060 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2006 | 65 | 0.060 |
Why?
|
| Cytokines | 1 | 2008 | 438 | 0.060 |
Why?
|
| Safety Management | 1 | 2005 | 13 | 0.060 |
Why?
|
| Montana | 1 | 2005 | 5 | 0.060 |
Why?
|
| Northwestern United States | 1 | 2005 | 9 | 0.060 |
Why?
|
| Epidemiologic Research Design | 1 | 2005 | 10 | 0.060 |
Why?
|
| Organizational Objectives | 1 | 2005 | 16 | 0.060 |
Why?
|
| Population Density | 1 | 2005 | 21 | 0.060 |
Why?
|
| Drug Monitoring | 1 | 2005 | 34 | 0.060 |
Why?
|
| Certification | 1 | 2005 | 15 | 0.060 |
Why?
|
| Biomechanical Phenomena | 1 | 2006 | 160 | 0.060 |
Why?
|
| Health Services Needs and Demand | 1 | 2005 | 36 | 0.060 |
Why?
|
| Accreditation | 1 | 2005 | 33 | 0.060 |
Why?
|
| Quality Indicators, Health Care | 1 | 2005 | 49 | 0.060 |
Why?
|
| Terminology as Topic | 1 | 2005 | 53 | 0.060 |
Why?
|
| Patient Care Team | 1 | 2005 | 63 | 0.060 |
Why?
|
| Treatment Outcome | 1 | 2011 | 2264 | 0.060 |
Why?
|
| Critical Illness | 1 | 2005 | 65 | 0.060 |
Why?
|
| Middle Aged | 2 | 2006 | 6818 | 0.060 |
Why?
|
| Antihypertensive Agents | 1 | 2004 | 57 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 4 | 2011 | 176 | 0.060 |
Why?
|
| Fluid Therapy | 1 | 2003 | 14 | 0.060 |
Why?
|
| Bone Marrow | 1 | 2003 | 76 | 0.050 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 1927 | 0.050 |
Why?
|
| Age Factors | 1 | 2005 | 716 | 0.050 |
Why?
|
| Warfarin | 1 | 2003 | 94 | 0.050 |
Why?
|
| Protein Structure, Secondary | 2 | 1992 | 130 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2005 | 843 | 0.050 |
Why?
|
| Laryngeal Masks | 1 | 2001 | 6 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2003 | 293 | 0.050 |
Why?
|
| Pediatric Nursing | 1 | 2000 | 3 | 0.040 |
Why?
|
| Professional-Family Relations | 1 | 2000 | 22 | 0.040 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 1999 | 3 | 0.040 |
Why?
|
| Family | 1 | 2000 | 98 | 0.040 |
Why?
|
| Azurin | 1 | 1999 | 2 | 0.040 |
Why?
|
| Rupture | 1 | 1999 | 11 | 0.040 |
Why?
|
| Adaptation, Psychological | 1 | 2000 | 117 | 0.040 |
Why?
|
| Patient Selection | 1 | 2000 | 143 | 0.040 |
Why?
|
| Young Adult | 1 | 2006 | 2581 | 0.040 |
Why?
|
| Pseudomonas aeruginosa | 1 | 1999 | 62 | 0.040 |
Why?
|
| Life Support Care | 1 | 1997 | 2 | 0.040 |
Why?
|
| Riboswitch | 1 | 2017 | 1 | 0.040 |
Why?
|
| Virulence Factors | 1 | 2017 | 45 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 57 | 0.030 |
Why?
|
| Electron Spin Resonance Spectroscopy | 2 | 2011 | 35 | 0.030 |
Why?
|
| Transcriptome | 1 | 2017 | 198 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 1992 | 674 | 0.030 |
Why?
|
| Adsorption | 1 | 2013 | 31 | 0.030 |
Why?
|
| Succinate Dehydrogenase | 1 | 2013 | 7 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 2013 | 24 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2013 | 59 | 0.030 |
Why?
|
| Surface Properties | 1 | 2013 | 132 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2013 | 115 | 0.030 |
Why?
|
| Infusions, Parenteral | 1 | 1993 | 34 | 0.030 |
Why?
|
| Analgesics | 1 | 1993 | 34 | 0.030 |
Why?
|
| Drug Stability | 1 | 1992 | 23 | 0.030 |
Why?
|
| Mathematics | 1 | 1992 | 42 | 0.030 |
Why?
|
| Hydrogen Bonding | 1 | 1992 | 39 | 0.030 |
Why?
|
| Hypnotics and Sedatives | 1 | 1993 | 29 | 0.030 |
Why?
|
| Crystallization | 1 | 1992 | 47 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1992 | 130 | 0.030 |
Why?
|
| Thermodynamics | 1 | 1992 | 86 | 0.030 |
Why?
|
| Ethers | 1 | 2012 | 5 | 0.030 |
Why?
|
| Drug Interactions | 1 | 1992 | 77 | 0.030 |
Why?
|
| Chelating Agents | 1 | 2012 | 21 | 0.020 |
Why?
|
| Zinc | 1 | 1992 | 57 | 0.020 |
Why?
|
| Hot Temperature | 1 | 1992 | 84 | 0.020 |
Why?
|
| Polymerization | 1 | 2012 | 14 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 400 | 0.020 |
Why?
|
| Oxides | 1 | 2011 | 14 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 439 | 0.020 |
Why?
|
| Electrochemical Techniques | 1 | 2011 | 20 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1992 | 586 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 1993 | 209 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 1992 | 1036 | 0.020 |
Why?
|
| Methylene Chloride | 1 | 2010 | 1 | 0.020 |
Why?
|
| Carbon Monoxide | 1 | 2010 | 47 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 50 | 0.020 |
Why?
|
| Dimerization | 1 | 2009 | 75 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 190 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 324 | 0.020 |
Why?
|
| Computational Biology | 1 | 2010 | 150 | 0.020 |
Why?
|
| Molecular Biology | 1 | 2007 | 16 | 0.020 |
Why?
|
| Animals | 1 | 1999 | 9960 | 0.020 |
Why?
|
| Triazoles | 1 | 2003 | 14 | 0.010 |
Why?
|
| Hydrocarbons | 1 | 2003 | 41 | 0.010 |
Why?
|
| Kinetics | 1 | 2003 | 538 | 0.010 |
Why?
|